北大医药
(000788)
| 流通市值：35.76亿 | | | 总市值：35.76亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 374,371,792.05 | 426,798,453.64 | 345,188,366.23 | 457,253,265.09 |
| 应收票据及应收账款 | 1,218,783,091.96 | 1,184,950,533.51 | 1,251,362,473.99 | 1,271,017,067.96 |
| 其中：应收票据 | 19,104,451.65 | 21,610,522.94 | 24,277,219.48 | 24,009,898.42 |
| 应收账款 | 1,199,678,640.31 | 1,163,340,010.57 | 1,227,085,254.51 | 1,247,007,169.54 |
| 应收款项融资 | 67,685,185.63 | 91,656,729.76 | 79,887,661.24 | 36,675,357.18 |
| 预付款项 | 27,667,715.01 | 13,194,724.91 | 23,146,661.18 | 15,630,901.66 |
| 其他应收款合计 | 67,266,579.38 | 104,309,457.92 | 103,916,596.01 | 88,182,899.68 |
| 存货 | 208,541,867.03 | 221,630,056.51 | 208,699,275.27 | 184,176,529.2 |
| 其他流动资产 | 1,971,391.56 | 2,219,093.36 | 4,101,678.85 | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,966,287,622.62 | 2,044,759,049.61 | 2,016,302,712.77 | 2,052,936,020.77 |
| 非流动资产: | | | | |
| 长期应收款 | 3,257,509.74 | 4,198,525.08 | 4,111,540.42 | - |
| 投资性房地产 | 16,010,169.31 | 16,336,907.47 | 16,663,645.63 | 16,990,383.79 |
| 固定资产 | 121,971,782.45 | 117,455,983.85 | 121,952,477.08 | 117,282,636.5 |
| 在建工程 | - | 4,835,494.45 | 3,043,362.84 | 7,307,964.6 |
| 使用权资产 | 26,370,131.82 | 31,941,664.56 | 37,513,197.3 | 43,084,730.04 |
| 无形资产 | 109,678,180.14 | 104,022,368.53 | 111,188,002.25 | 114,687,374.87 |
| 开发支出 | 19,360,593.13 | 21,308,209.69 | 16,671,205.35 | 14,096,917.97 |
| 递延所得税资产 | 7,450,819.93 | 8,227,082.7 | 16,996,109.08 | 18,441,457.85 |
| 其他非流动资产 | 57,439,682.79 | 57,637,796.01 | 50,462,041.29 | 53,458,639.69 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 361,538,869.31 | 365,964,032.34 | 378,601,581.24 | 385,350,105.31 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,327,826,491.93 | 2,410,723,081.95 | 2,394,904,294.01 | 2,438,286,126.08 |
| 流动负债: | | | | |
| 短期借款 | - | 32,038,666.66 | 32,000,000 | 35,091,178.24 |
| 应付票据及应付账款 | 486,106,563.4 | 541,113,930.84 | 527,252,370.9 | 529,916,493.38 |
| 其中：应付票据 | 81,629,166.43 | 104,113,058.02 | 78,191,574.1 | 63,205,468.91 |
| 应付账款 | 404,477,396.97 | 437,000,872.82 | 449,060,796.8 | 466,711,024.47 |
| 预收款项 | - | - | 30,174.93 | 30,174.93 |
| 合同负债 | 11,406,339.58 | 10,730,554.68 | 10,535,673.68 | 12,982,623.57 |
| 应付职工薪酬 | 24,309,899.63 | 19,870,644.17 | 17,541,285.42 | 37,446,772.96 |
| 应交税费 | 20,014,388.4 | 11,961,275.23 | 29,210,002.14 | 25,927,110.29 |
| 其他应付款合计 | 202,023,627.28 | 252,923,118.52 | 255,747,571.89 | 301,519,632.36 |
| 应付股利 | - | 15,495,673.05 | - | - |
| 一年内到期的非流动负债 | 22,432,748.72 | 22,248,605.65 | 22,141,537.64 | 23,504,078.49 |
| 其他流动负债 | 1,482,824.1 | 1,396,792.07 | 1,367,079.91 | 1,687,741.06 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 767,776,391.11 | 892,283,587.82 | 895,825,696.51 | 968,105,805.28 |
| 非流动负债: | | | | |
| 租赁负债 | 5,910,218.62 | 11,619,105.98 | 17,841,126.33 | 23,542,320.69 |
| 预计负债 | - | - | - | 12,090,042 |
| 递延收益 | 17,910,685.04 | 14,112,288.95 | 13,438,053.95 | 13,136,818.99 |
| 递延所得税负债 | - | - | 2,352,669.82 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 23,820,903.66 | 25,731,394.93 | 33,631,850.1 | 48,769,181.68 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 791,597,294.77 | 918,014,982.75 | 929,457,546.61 | 1,016,874,986.96 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 595,987,425 | 595,987,425 | 595,987,425 | 595,987,425 |
| 资本公积 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 |
| 盈余公积 | 62,032,824.18 | 62,032,824.18 | 56,403,337.67 | 56,403,337.67 |
| 未分配利润 | 679,733,653.86 | 636,194,060.98 | 614,540,730.82 | 570,493,824.69 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,536,926,837.92 | 1,493,387,245.04 | 1,466,104,428.37 | 1,422,057,522.24 |
| 少数股东权益 | -697,640.76 | -679,145.84 | -657,680.97 | -646,383.12 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,536,229,197.16 | 1,492,708,099.2 | 1,465,446,747.4 | 1,421,411,139.12 |
| 负债和股东权益合计 | 2,327,826,491.93 | 2,410,723,081.95 | 2,394,904,294.01 | 2,438,286,126.08 |
| 公告日期 | 2024-10-26 | 2024-08-30 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |